Primary care physicians play a significant role in managing heart failure (HF), with the goals
of reducing mortality, avoiding hospitalization, and improving patients' quality of life. Most HF …

Aims In heart failure, non‐adherence increases events; in turn, the effect of hospitalization
on adherence is incompletely understood. We explored the relationship of non‐adherence …

Aims A post‐hoc analysis of the SHIFT trial was performed to explore whether ivabradine is
beneficial in patients with systolic heart failure, in sinus rhythm, with resting heart rate≥ 70 …

Objective: To review the role of heart rate in myocardial ischemia and heart failure with
reduced ejection fraction (HFrEF) as well as ivabradine's pharmacology and …

Background After a heart failure (HF) hospital discharge, the risk of a cardiovascular (CV)
related event is highest in the following 100 days. It is important to identify factors associated …

Background: Hospitals that provide early postdischarge follow-up after heart failure (HF)
hospitalization tend to have lower rates of readmission. However, HF postdischarge (bridge) …

Heart failure (HF) affects more than 6 million people in the United States. 1, 2 An estimated
92 million adults in the United States have cardiovascular disease in some capacity. By the …

Background It is unknown whether causes and temporal patterns of 30‐day readmission
vary between heart failure (HF) with preserved ejection fraction (HF p EF) and HF with …

Aims This randomized, double‐blind, placebo‐controlled trial assessed whether heart rate
(HR) reduction with ivabradine improves cardiac function in heart failure with preserved …

Increased heart rate (HR) is associated with deleterious effects on several disease
conditions. Chronic heart failure (CHF) is one of the cardiovascular diseases with recurrent …